We are live on ! Find out more
SCI

S&CO Inc Portfolio holdings

AUM $1.61B
1-Year Est. Return 21.39%
This Fund
S&P 500
This Quarter Est. Return
+2.14%
1 Year Est. Return
+21.39%
3 Year Est. Return
+58.88%
5 Year Est. Return
+84.19%
10 Year Est. Return
+267.05%
AUM
$1.61B
AUM Growth
+$1.96M
Cap. Flow
+$20.1M
Cap. Flow %
1.25%
Top 10 Hldgs %
38.55%
Holding
222
New
4
Increased
36
Reduced
58
Closed
4

Top Sells

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$4.55M
2
CCJ icon
Cameco
CCJ
+$3.29M
3
ABT icon
Abbott
ABT
+$3.05M
4
SIRI icon
SiriusXM
SIRI
+$2.58M
5
MIDD icon
Middleby
MIDD
+$1.93M

Sector Composition

Rank Sector Weight
1 Healthcare 17.08%
2 Technology 16.29%
3 Financials 11.19%
4 Energy 10.08%
5 Industrials 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
151
Coca-Cola
KO
$351B
$778K 0.05%
10,236
CET
152
Central Securities Corp
CET
$1.55B
$768K 0.05%
15,469
-4
-0% -$206
MTD icon
153
Mettler-Toledo International
MTD
$26.5B
$756K 0.05%
600
SXI icon
154
Standex International
SXI
$3.67B
$684K 0.04%
2,685
IWF icon
155
iShares Russell 1000 Growth ETF
IWF
$123B
$657K 0.04%
6,168
-40
-0.6% -$4.54K
KMPR icon
156
Kemper
KMPR
$1.65B
$607K 0.04%
19,870
LILAK icon
157
Liberty Latin America Class C
LILAK
$1.48B
$607K 0.04%
75,797
-235,350
-76% -$1.68M
PNC icon
158
PNC Financial Services
PNC
$101B
$582K 0.04%
2,800
BEN icon
159
Franklin Resources
BEN
$17B
$549K 0.03%
23,245
-23,250
-50% -$598K
BE icon
160
Bloom Energy
BE
$61.1B
$541K 0.03%
4,000
-1,000
-20% -$147K
CRM icon
161
Salesforce
CRM
$140B
$529K 0.03%
2,839
RARE icon
162
Ultragenyx Pharmaceutical
RARE
$2.88B
$529K 0.03%
25,255
ZTS icon
163
Zoetis
ZTS
$32.1B
$521K 0.03%
4,410
-414
-9% -$51.2K
INTC icon
164
Intel
INTC
$478B
$517K 0.03%
11,734
IQV icon
165
IQVIA
IQV
$34.4B
$511K 0.03%
3,000
GIS icon
166
General Mills
GIS
$20.3B
$507K 0.03%
13,646
-2,000
-13% -$86.8K
DE icon
167
Deere & Co
DE
$161B
$484K 0.03%
860
BAH icon
168
Booz Allen Hamilton
BAH
$7.82B
$457K 0.03%
5,860
IWO icon
169
iShares Russell 2000 Growth ETF
IWO
$14.7B
$417K 0.03%
1,329
VEA icon
170
Vanguard FTSE Developed Markets ETF
VEA
$226B
$394K 0.02%
6,150
TXN icon
171
Texas Instruments
TXN
$258B
$388K 0.02%
2,000
-70
-3% -$14.2K
AVGO icon
172
Broadcom
AVGO
$1.76T
$385K 0.02%
1,245
GLIBA
173
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$881M
$377K 0.02%
10,254
+5
+0% +$190
EBC icon
174
Eastern Bankshares
EBC
$4.94B
$358K 0.02%
18,305
ZWS icon
175
Zurn Elkay Water Solutions
ZWS
$7.96B
$358K 0.02%
8,000

Similar funds

S&CO Inc's Q1 2026 Portfolio in Review

As of Q1 2026, S&CO Inc held 222 positions worth $1.61B, up 0.12% from $1.61B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.6%. S&CO Inc opened 4 new positions and exited 4, leaving the 222-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

  • S&CO Inc's largest Q1 2026 buy was AstraZeneca: 50,765 shares worth $9.83M.
  • S&CO Inc added most to Microsoft in Q1 2026, an estimated $7.49M increase.
  • S&CO Inc's biggest Q1 2026 reduction was Caterpillar, cutting an estimated $4.55M.
  • S&CO Inc fully exited Canadian Pacific Kansas City in Q1 2026, selling an estimated $1.03M.
  • S&CO Inc's ten largest holdings make up 39% of its $1.61B portfolio in Q1 2026.
  • S&CO Inc opened 4 new positions and closed 4 in Q1 2026.
  • S&CO Inc's portfolio value rose 0.12% quarter-over-quarter to $1.61B.

Based on S&CO Inc's 13F filing for Q1 2026, filed 7 May 2026.